Firms to develop freeze-dried human plasma

Entegrion and Kedrion Melville agreed to collaborate in the development and commercialization of the former's freeze-dried human plasma Resusix, a shelf-stable alternative to fresh-frozen plasma. The partners plan to initiate clinical studies this year. Kedrion will invest in Entegrion under the agreement.

View Full Article in:

American City Business Journals · WRALTechWire.com (Raleigh, N.C.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY